Radnet Inc Revenue per Employee (RDNT), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Radnet Inc   (NASDAQ: RDNT)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Radnet Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 22.07% in the third quarter 2026, year on year to cumulative value of $2,384 million, Radnet Inc 's revenue per employee grew on a trailing twelve months basis to $ 302,886. The productivity of Radnet Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 334 other companies have achieved higher revenue per employee. While Radnet Inc 's total ranking has deteriorated compared to the previous quarter from 2019 to 2618. Radnet Inc has 7,872 employees.


What is Sales per Employee Ratio?







RDNT Revenue per Employee (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Revenue Change 22.07 % 24.99 % 22.11 % 14.8 % 13.39 %
Sales per Employee (TTM) $ 302,886 288,228 272,414 259,173 250,203
RDNT's Total Ranking # 2618 # 2019 # 1740 # 2448 #
Seq. Revenue Change 2.5 % 8.18 % 5.1 % 4.75 % 4.95 %


Revenue per Employee Company Ranking
Within: No.
Medical Laboratories Industry # 18
Healthcare Sector # 335
Overall Market # 2618

Revenue per Employee Statistics
High Average Low
$ 288,228 $ 151,063 $ 20,846
(Jun 30 2026)   (Sep 30 2013)



Financial Statements
Radnet Inc 's Revenue MRQ $ 638 Millions Visit RDNT's Income Statement
Radnet Inc 's Revenues TTM $ 2,384 Millions Visit RDNT's aggregate revenue growth
What are RDNT's Sales? Visit RDNT's Sales by Segment


  News about Radnet Inc Revenue per employee

RadNet Reduces Interest Rates and Celebrates Record Revenue While Pioneering AI Innovations in Diagnostic Imaging,

IntroductionIn a significant financial maneuver, RadNet, Inc. (NASDAQ: RDNT), a leader in outpatient diagnostic imaging services, has announced the reduction of its credit facility interest rates. This comes hand-in-hand with impressive revenue growth, highlighting RadNet s resilience and tactical positioning in the competitive healthcare landscape. Additionally, the company is set to leverage cutting-edge technology through a recent collaboration with GE HealthCare, further expanding its commitment to innovative healthcare solutions.Reduction in Interest RatesOn November 22, 2024, RadNet announced the successful pricing and allocation for Amendment No. 1 to its Credit and Guaranty Agreement. The First Amendment allows for a 0.25% reduction in interest rates under its Third Amended and Restated First Lien Credit and Guaranty Agreement. This strategic position is expected to enhance RadNet s financial flexibility, allowing for potential reinvestment in state-of-the-art imaging technologies and infrastructure.




Other Ratios
Radnet Inc 's Income per Employee
Employees in Medical Laboratories
Medical Laboratories Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
RDNT's Revenue per Employee versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for RDNT's Competitors
Revenue per Employee for RDNT's Suppliers
Revenue per Employee for RDNT's Customers

You may also want to know
RDNT's Sales Growth Rates RDNT's Pe Price to earnings ratio RDNT's Receivables Turnover Ratio RDNT's Stock Quote
RDNT's Net Income Growth Rates RDNT's Ps Price to Sales ratio RDNT's Sales per Employee RDNT's Asset Turnover Ratio
RDNT's Net Margin RDNT's Pb Price to Book ratio RDNT's Financial Strength Ratios RDNT's Dividend Payout Ratio
Date modified: 2026-11-10T05:39:25+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Glaukos Corp  528,660.88 $ 578.355  Million 1,094 
Angiodynamics Inc   512,316.46 $ 323.784  Million 632 
Resmed Inc   505,115.57 $ 5,743.164  Million 11,370 
Avantor Inc   491,525.93 $ 6,635.600  Million 13,500 
Lexicon Pharmaceuticals Inc   475,765.43 $ 38.537  Million 81 
Stryker Corp  469,642.86 $ 26,300.000  Million 56,000 
Monte Rosa Therapeutics Inc   468,833.33 $ 70.325  Million 150 
Dexcom Inc   459,900.90 $ 5,104.900  Million 11,100 
Medpace Holdings Inc   457,804.03 $ 2,838.385  Million 6,200 
Haemonetics Corporation  457,405.56 $ 1,382.737  Million 3,023 
Novocure Limited  451,955.14 $ 725.388  Million 1,605 
Omniab Inc   451,808.99 $ 40.211  Million 89 
Teladoc Health Inc   440,739.82 $ 2,468.143  Million 5,600 
Orthopediatrics Corp  437,981.73 $ 263.665  Million 602 
Vanda Pharmaceuticals Inc   430,165.10 $ 229.278  Million 533 
Axogen inc   429,141.48 $ 266.926  Million 622 
Idexx Laboratories Inc  423,970.45 $ 4,663.675  Million 11,000 
3m Company  417,305.79 $ 25,247.000  Million 60,500 
Bausch and Lomb Corp  416,769.23 $ 5,418.000  Million 13,000 
Regenxbio Inc   414,854.45 $ 153.911  Million 371 
Teva Pharmaceutical Industries Limited  412,960.24 $ 14,020.000  Million 33,950 
Lemaitre Vascular Inc   412,119.08 $ 269.938  Million 655 
Sotera Health Company  410,083.33 $ 1,230.250  Million 3,000 
Cryo cell International Inc   409,559.89 $ 31.127  Million 76 
Innovage Holding Corp   407,343.60 $ 1,018.359  Million 2,500 
Brightspring Health Services Inc   403,367.83 $ 9,479.144  Million 23,500 
Repligen Corp  402,805.00 $ 805.610  Million 2,000 
Strata Critical Medical Inc   393,386.02 $ 236.425  Million 601 
Iovance Biotherapeutics inc   388,700.51 $ 378.983  Million 975 
Pro dex Inc   386,300.97 $ 79.578  Million 206 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.